EVEREST ORGANICS
Back to Cashflow Statement
|
EVEREST ORGANICS Last 5 Year Cash Flow from Investing Activities History
[Standalone]
| Mar2025 | Mar2024 | Mar2023 | Mar2022 | Mar2021 | |
|---|---|---|---|---|---|
| Cash Flow from Investing Activities | ₹-5.17 Cr | ₹-13 Cr | ₹-16 Cr | ₹-17 Cr | ₹-12 Cr |
What is the latest Cash Flow from Investing Activities ratio of EVEREST ORGANICS ?
| Year | Cash Flow from Investing Activities |
|---|---|
| Mar2025 | ₹-5.17 Cr |
| Mar2024 | ₹-13 Cr |
| Mar2023 | ₹-16 Cr |
| Mar2022 | ₹-17 Cr |
| Mar2021 | ₹-12 Cr |
How is Cash Flow from Investing Activities of EVEREST ORGANICS Trending?
| Years | Cash Flow from Investing Activities | % Change | |
|---|---|---|---|
| Mar2025 | ₹-5.17 Cr | Negative | |
| Mar2024 | ₹-13 Cr | Negative | |
| Mar2023 | ₹-16 Cr | Negative | |
| Mar2022 | ₹-17 Cr | Negative | |
| Mar2021 | ₹-12 Cr | - | |
Compare Cash Flow from Investing Activities of peers of EVEREST ORGANICS
| Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
| EVEREST ORGANICS | ₹247.2 Cr | -5.3% | -15.3% | -39.3% | Stock Analytics | |
| SUN PHARMACEUTICAL INDUSTRIES | ₹448,196.0 Cr | -0.4% | -3.3% | 15.5% | Stock Analytics | |
| DIVIS LABORATORIES | ₹250,390.0 Cr | 0.4% | 9.9% | 55.1% | Stock Analytics | |
| TORRENT PHARMACEUTICALS | ₹188,967.0 Cr | -3.4% | -4.2% | 37.1% | Stock Analytics | |
| CIPLA | ₹111,888.0 Cr | 0.5% | -3.2% | -12.8% | Stock Analytics | |
| DR REDDYS LABORATORIES | ₹100,329.0 Cr | 0.9% | 0% | -11% | Stock Analytics | |
EVEREST ORGANICS Share Price vs Sensex
| Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
| EVEREST ORGANICS | -5.3% |
-15.3% |
-39.3% |
| SENSEX | 0.1% |
-2.7% |
-8.6% |
You may also like the below Video Courses